Testing for bloodborne viruses, including hepatitis C, in a remand prison poses challenges for prison healthcare staff. If untreated, hepatitis C can lead to cirrhosis, liver cancer or liver failure, but early identification and treatment can prevent liver damage.
An article in Nursing Times explains how one remand prison in the UK changed from dry blood spot testing to rapid oral swabs with confirmatory viral load testing, using a rapid molecular testing machine. The initiative also secured the involvement of prisoner peers. Combined, this approach led to an increase in the number of prisoners tested and subsequently treated with hepatitis C antiviral therapy, as well as normalising testing within the prison and reducing any associated stigma.
Access the full article here.
Source : Nursing Times
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.